The initial public offering (IPO) market has been a barren wasteland recently, but investors now have something to look ahead to. Johnson & Johnson announced that its consumer health spinoff company Kenvue will IPO later this 12 months.
Kenvue might be valued around $40 billion by the point of the IPO. And it might be the biggest IPO this 12 months.
On this episode of Startup Insider, Vin Narayanan explains why that is opportunity for investors to gauge market interest in IPOs.
Get Early Investing into your inbox
Develop into a wiser investor in startups, crypto and cannabis by subscribing to our FREE newsletter stuffed with market research, trends and expert evaluation.
Thanks for watching!